Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma
Immunotherapy may have been given too late, researchers suggested
Source: medpagetoday.com
Stay updated with breaking news from Jeff Minerd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immunotherapy may have been given too late, researchers suggested
Risk for delayed graft function higher, but other endpoints no different
Study identified factors and strategies for maintaining response
Study suggested risks may outweigh benefits for some older patients
Biosimilar approved; clinical trial data supports early intensive therapy